BridgeBio Pharma Stock (NASDAQ:BBIO), Quotes and News Summary

Q: What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BridgeBio Pharma Stock (NASDAQ: BBIO) stock price, news, charts, stock research, profile.

Open	$25.370
Close	-
Volume / Avg.	44.775K / 1.694M
Day Range	25.300 - 25.780
52 Wk Range	12.750 - 44.320
Market Cap	$4.687B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	12.19%
Days to Cover	9.18

Recent News

What's Going On With BridgeBio Pharma Stock On Monday?

BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted.

Vandana Singh

Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Avi Kapoor

Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today?

Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all primary

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About BridgeBio Pharma Inc

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients w...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BridgeBio Pharma (BBIO) stock?

You can purchase shares of BridgeBio Pharma (NASDAQ: BBIO) through any online brokerage.

View our list of the best stock brokerages.

Who are BridgeBio Pharma's (BBIO) competitors?

Other companies in BridgeBio Pharma’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for BridgeBio Pharma (BBIO) stock?

The latest price target for BridgeBio Pharma (NASDAQ: BBIO) was reported by JP Morgan on Wednesday, March 20, 2024. The analyst firm set a price target for 45.00 expecting BBIO to rise to within 12 months (a possible 77.30% upside). 18 analyst firms have reported ratings in the last year.

Current Stock Price for BridgeBio Pharma (BBIO)?

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $25.38 last updated Today at April 24, 2024 at 9:44 AM EDT.

Does BridgeBio Pharma (BBIO) pay a dividend?

There are no upcoming dividends for BridgeBio Pharma.

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

BridgeBio Pharma’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is BridgeBio Pharma (BBIO) going to split?

There is no upcoming split for BridgeBio Pharma.

What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-